Report on Activities for the Quarter ended 31 March 2024 26 April 2024 by Audrey Thomson Report on Activities for the Quarter Ended 31 March 2024
Positive Outcomes in BIT225 Phase 2 Clinical Trial in HIV-1 (BIT225-010) 5 April 2024 by Audrey Thomson Positive Outcomes in BIT225 Phase 2 Clinical Trial in HIV (BIT225-010)
Half-year Report 31 December 2023 27 February 2024 by Audrey Thomson Half-year Report 31 December 2023
Report on Activities for the Quarter ended 31 December 2023 30 January 2024 by Audrey Thomson Report on Activities for the Quarter Ended 31 December 2023
Quarterly Report 31 December 2023 30 January 2024 by Audrey Thomson Quarterly Report 31 December 2023
Presentation to Annual General Meeting 23 November 202322 November 2023 by Audrey Thomson Presentation to Annual General Meeting
Results of Annual General Meeting 23 November 202322 November 2023 by Audrey Thomson Results of Annual General Meeting